Patent Assignment
Reel/Frame 064719/0614
Corrective Assignment to Correct the Country Is "United Kingdom" Previously Recorded at Reel: 064583 Frame: 0014. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-08-25
Pages: 10
Assignee
GW RESEARCH LIMITED
SOVEREIGN HOUSE, VISION PARK, CHIVERS WAY, HISTON, CAMBRIDGE, CAMBRIDGE, CB24 9BZ, UNITED KINGDOM
Covered Property
(1)
Use of Cannabidivarin in the Treatment of Seizures Associated with Rare Epilepsy Syndromes Related to Genetic Abnormalities
Application:
18/044,941 →
Publication:
US 2023/0346809
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 14, 2023
From: CRAIG, KEVIN JAMES; LAWSON, JOHN ANTHONY
To: GW RESEARCH LIMITED
Reel/Frame 064583/0014 →
Security Agreement
Jul 26, 2024
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; GW PHARMA LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 068173/0155 →
Change of Name
May 19, 2025
From: GW RESEARCH LIMITED
To: JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Reel/Frame 071152/0715 →